Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05301140 Vivistim Registry for Paired VNS Therapy (GRASP) |
Vivistim System | SEP | À vérifier | RECRUITING | En attente / non publié | MicroTransponder Inc. | United States · Advent Health Orlando, Orlando, Unite… | 2023-03-15 → 2028-12-31 | Ouvrir |
| NCT00215215 Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS … |
Vagus Nerve Stimulation Therapy | SEP | Phase 4 | TERMINATED | En attente / non publié | Cyberonics, Inc. | United States · Bronislav Shafran, M.D., P.C., Phoeni… | 2005-02 → 2007-11 | Ouvrir |
| NCT06985043 The Effect of Vagus Nerve Stimulation on Lower Limb Muscle Strength and… |
Auricular vagus nerve stimulation… | SEP | Non applicable | COMPLETED | En attente / non publié | Bahçeşehir University | Turkey (Türkiye) · Bahcesehir university, Istanbul, T… | 2025-05-25 → 2025-07-25 | Ouvrir |
| NCT01118455 Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug… |
Vagus Nerve Stimulation (VNS) The… | SEP | Phase 4 | TERMINATED | En attente / non publié | Cyberonics, Inc. | Austria, Belgium, Germany, Sweden, United Kingdom · A… | 2004-10 → 2010-01 | Ouvrir |
| NCT03440255 Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center |
transcutaneous vagus nerve stimul… | SEP | Non applicable | COMPLETED | En attente / non publié | Kyoungwon Baik | Canada · Kinesis Health Associates, Dartmouth, Canada | 2017-07-01 → 2017-09-15 | Ouvrir |
| NCT05967598 Effect of taVNS of Brainstem Activation in Early and Late Parkinson's D… |
Noninvasive transcutaneous auricu… | SEP | Non applicable | COMPLETED | En attente / non publié | University of Ljubljana | Slovenia · Neurology Department, UMC Ljubljana, Ljubl… | 2023-02-15 → 2023-09-29 | Ouvrir |
| NCT06865274 PoGe — Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromye… |
Blood draw for the laboratory ass… | SEP | Non applicable | RECRUITING | En attente / non publié | Fondazione Policlinico Universita… | Italy · Fondazione Policlinico Universitario Agostino… | 2025-02-20 → 2027-02-28 | Ouvrir |
| NCT05902429 CLAREMI — Effects of Oral Cladribine on Remyelination and Inflammation … |
Cladribine 10 mg oral tablet | SEP | Phase 4 | UNKNOWN | En attente / non publié | Pontificia Universidade Católica … | Brazil · Pontifical Catholic University of Rio Grande… | 2021-04-28 → 2024-08 | Ouvrir |
| NCT02446886 Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects W… |
Adrenocorticotropic hormone (ACTH… | SEP | Phase 4 | TERMINATED | En attente / non publié | Weill Medical College of Cornell … | United States · Weill Cornell Medicine, New York, Uni… | 2016-06 → 2020-06 | Ouvrir |
| NCT07653984 RANID — Cohort Study on Neuroimmune Diseases in the Reproductive Age |
RANID — Cohort Study on Neuroimmu… | SEP | À vérifier | RECRUITING | En attente / non publié | Third Affiliated Hospital, Sun Ya… | China · The Third Affiliated Hospital, Sun Yat-sen Un… | 2024-04-21 → 2030-04 | Ouvrir |
| NCT05746845 RESEPTOR 5-HT7 — Implication of 5-HT7 Receptor in Inflammatory Mechanis… |
Blood sample | SEP | À vérifier | COMPLETED | En attente / non publié | Centre Hospitalier Régional d'Orl… | France · CHU Orléans, Orléans, France | 2023-03-06 → 2024-07-01 | Ouvrir |
| NCT02861014 A Study of Ocrelizumab in Participants With Relapsing Remitting Multipl… |
Ocrelizumab | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | Australia, Belgium, Czechia, Denmark, Estonia, Finlan… | 2016-09-09 → 2020-12-15 | Ouvrir |
| NCT04902690 The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Exp… |
The Possible Neuroprotective Effe… | SEP | À vérifier | UNKNOWN | En attente / non publié | IRCCS National Neurological Insti… | Non communiqué | 2021-05-31 → 2024-07-31 | Ouvrir |
| NCT04863586 COVID-19 and Multiple Sclerosis Disease Modifying Therapies |
COVID-19 and Multiple Sclerosis D… | SEP | À vérifier | UNKNOWN | En attente / non publié | Nottingham University Hospitals N… | United Kingdom · Nottingham University Hospitals NHS … | 2021-04-01 → 2022-05-31 | Ouvrir |
| NCT05208840 LEGATO — A Study To Determine The Effect Of Ocrelizumab On Leptomeninge… |
Ocrelizumab | SEP | Phase 4 | WITHDRAWN | En attente / non publié | Hoffmann-La Roche | Russia · City Clinical Hospital #24; Multipal Scleros… | 2023-09-15 → 2026-01-31 | Ouvrir |
| NCT07380022 PHYTASE — Acceptability, Adherence, and Impact on the Bioavailability o… |
PHYTASE — Acceptability, Adherenc… | SEP | Non applicable | COMPLETED | En attente / non publié | University of Thessaly | Greece · School of Physical Education, Sport Science … | 2025-07-09 → 2026-02-28 | Ouvrir |
| NCT06699095 HoReConCareMS — Home Rehabilitation as Continuity of Care in MS |
Telerehabilitation | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Fondazione I.R.C.C.S. Istituto Ne… | Italy · Fondazione IRCCS Istituto Neurologico Carlo B… | 2024-11-06 → 2026-11-15 | Ouvrir |
| NCT07555015 An Online Nurse-Led Purpose-Focused Group Program for Adult Women With … |
An Online Nurse-Led Purpose-Focus… | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Texas Woman's University | United States · Texas Woman's University, Denton, Uni… | 2026-07-14 → 2026-09 | Ouvrir |
| NCT04777539 Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®… |
Tys at Home — Comparing the Safet… | SEP | À vérifier | COMPLETED | En attente / non publié | Nantes University Hospital | France · Adolphe de Rothschild Ophthalmological Found… | 2021-06-14 → 2025-05-14 | Ouvrir |
| NCT00794352 Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the… |
Comprehensive Multimodal Analysis… | SEP | À vérifier | RECRUITING | En attente / non publié | National Institute of Allergy and… | United States · National Institutes of Health Clinica… | 2008-10-01 | Ouvrir |
| NCT06617793 An Open-label Study to Assess the Safety, Efficacy, and Cellular Kineti… |
rapcabtagene autoleucel (YTB323) | SEP | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Stanford University | Australia, France, Germany, Italy, Spain, Switzerland… | 2025-02-24 → 2030-08-07 | Ouvrir |
| NCT03500328 TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Scl… |
TREAT-MS — Traditional Versus Ear… | SEP | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Johns Hopkins University | United States · Advanced Neurology Specialists, Great… | 2018-05-02 → 2026-09 | Ouvrir |
| NCT06796504 The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitt… |
Implant Procedure | SEP | Non applicable | RECRUITING | En attente / non publié | SetPoint Medical Corporation | United States · Johns Hopkins School of Medicine, Bal… | 2026-04-17 → 2030-09-30 | Ouvrir |
| NCT05285891 AMS05 — Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis |
Ocrelizumab | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States · Icahn School of Medicine at Mount Sin… | 2023-02-07 → 2032-02-25 | Ouvrir |
| NCT07800039 MS-PILATES — Clinical Pilates for Balance and Function in Multiple Scle… |
MS-PILATES — Clinical Pilates for… | SEP | Non applicable | COMPLETED | En attente / non publié | University of Patras | Greece · Home-Based Study Site, Ioannina, Greece | 2024-05-30 → 2024-09-10 | Ouvrir |